Know what’s really happening at
SonoThera before you sign on.
- On the roadmap
- Gene Therapy
- Drug Delivery
- Biotechnology
SonoThera is pioneering ultrasound-mediated, nonviral gene therapy designed to overcome the safety, efficacy, and cost limitations of current gene therapies. Backed by a deep syndicate of top-tier biotech investors, the company is positioning itself to reshape how genetic medicines are delivered.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
SonoThera
- Series B Raised (June 2026)
- $125M
- Total Funding
- $185.75M
- Year Founded
- 2021
- Employee Count
- 56
- Lead Investor
- ARCH Venture Partners
- Headquarters
- South San Francisco, California, United States
- Company Size Range
- 51-200
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- Gene Therapy landscape
- Gene Therapy growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- SonoThera TAM
- Gene Therapy market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does SonoThera do
- SonoThera product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- SonoThera customers
- who uses SonoThera
- SonoThera ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- SonoThera competitors
- SonoThera alternatives
- who competes with SonoThera
- SonoThera win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- SonoThera reviews
- SonoThera NRR
- SonoThera churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- SonoThera investment thesis
- SonoThera moat
- bull case bear case
- SonoThera risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- SonoThera ARR
- SonoThera revenue
- SonoThera valuation
- unit economics
Team and culture
Founders, leadership, and org.
- SonoThera founders
- SonoThera CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
Analysis based on structured company profile data, funding records, and public investor information.